coiaward2010

EHA asks patients to report the unavailability of hematology medicines in Europe

The European Hematology Association (EHA) has developed a website survey where doctors, patients and healthcare professionals can report unavailability of medicines for haematological diseases. Over the course of the following months, EHA will collect and analyze these reports so that we can develop a coherent picture of the scope, causes and consequences of these problems in Europe. At the moment such an overview does not exist which makes it difficult for European politicians and policy makers to take measures that are effective have high impact.

As the success of our efforts fully depends on the quantity and quality of reports, EHA has asked for our help: If you are aware about unavailability of medicines in Europe, please go to EHA's survey at https://www.surveymonkey.com/s/GWH3DK5.

EHA will make all collected evidence publically available, so it is also of use for our community.


 
   
 

Please donate!

Please donate!

LogIn

Tweet Feed

cmlnet
"#Access is the complete process until #patient can get the drug" #patientadvocates session #eha22 #cml #leukemiatwitter.com/i/web/status/8…

Saturday, 24 June 2017

cmlnet
"Value based pricing implies that if a medicine is better a higher price should be paid" @WHO #eha22 #advocacy sess… twitter.com/i/web/status/8…

Saturday, 24 June 2017

cmlnet
S.Garner Fixing fundamental flaws in medicine pricing:what can regulators and public health authorities do? Fair Pr… twitter.com/i/web/status/8…

Saturday, 24 June 2017